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I. INTRODUCTION

At a July 30, 1999 Congressional hearing, an investigative journalist testified that
he was able to order Viagra for his cat, Tom, using the cat’s actual height and
weight.2 In other instances, the reporter and a colleague were able to obtain Viagra
for a ninety-eight year old man and a prescription diet drug for a seven-year-old girl.3
In testimony before the same Congressional subcommittee, Dr. Janet Woodcock, the
director of the Center for Drug Evaluation and Research at the U.S. Food and Drug
Administration [hereinafter “FDA”] said FDA investigators have found websites
offering kits for making homemade drugs, home abortion kits, and unapproved HIV
home test kits.4 Woodcock complained of doctors who work with (or for) online
pharmacies, sending prescriptions across the Internet on the basis of an electronic
questionnaire.5 Woodcock said some of the physicians prescribe to anyone sight
unseen – perhaps like “Tom” – without even requiring a questionnaire.6
As Woodcock and her colleagues have learned, Internet pharmacies are a
nightmare for regulators. The unique qualities of e-commerce make it difficult to
regulate under any circumstances, but the growth of online pharmacies in particular
is far outpacing the ability of government officials to investigate and enforce existing
1
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drug laws. In 1999, Americans spent an estimated $44 million purchasing
prescription drugs from online pharmacies, a figure that is projected to reach $1
billion per year by 2003.7 In December of 1999, President Clinton proposed $10
million in new funding for the FDA to regulate Internet pharmacies and hire 100 new
employees,8 but the FDA has yet to explain whether this would be enough to keep up
with the rapid growth of online pharmacies. Clinton also proposed raising civil fines
as high as $500,000 for pharmacies and pharmacists who violate state and federal
drug laws, and he proposed giving the FDA administrative subpoena authority.9
Several members of Congress have proposed their own legislation,10 and last year
Democrats on the House Commerce Committee asked the General Accounting
Office to investigate online pharmacies.11 This paper will consider the current laws
governing online pharmacies (to the limited extent the state of the law can be
discerned), the practical limits of traditional regulation and enforcement, and
possible legal and regulatory responses to online pharmacies.
II. THE NEW TELEMEDICINE
“Telepharmacy” could have an enormous impact on the legal and regulatory
boundaries of the overall field of telemedicine and perhaps electronic commerce in
general. Online pharmacies are a collision in progress between the free-wheeling
atmosphere of the Internet and one of the most tightly regulated industries in the
United States. On December 28, 1999, when President Clinton proposed the new
enforcement powers for the FDA, it marked the first major attempt by the federal or
state governments to regulate electronic commerce other than child pornography.12
Even at this early stage, online pharmacies are capable of raising Constitutional
questions of state police powers versus federal regulation of interstate commerce.
State and federal officials will be forced to reconsider what constitutes the practice of
medicine and who should regulate it. Legal and ethical questions for physicians –
not just pharmacists – appear to be arising much more quickly in the context of
telepharmacy than the traditional realm of telemedicine.13
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Yet to some extent, the recent regulatory hoopla about Internet pharmacies can be
misleading. To be sure, online pharmacies raise plenty of novel legal questions, but
many of the legal issues pertinent to online pharmacies have already been raised in
analogous areas of practice, such as mail-order pharmacy and telemedicine. What
appears to have changed is the volume of activity and the practicality of
enforcement: the amount of prescription drugs intercepted by the U.S. Customs
Service is a good indicator of the growth in sales. “We’ve been deluged with
prescription drugs coming in from overseas,” said U.S. Customs Service
Commissioner Raymond Kelly in an interview with the New York Times.14 “It’s a
major challenge to deal with this huge increase in volume.”15 In 1999, the Customs
Service seized 9725 packages with prescription drugs, up from 2145 packages the
year before.16 The number of pills and tablets impounded jumped from 760,720 in
1998 to 1.9 million in 1999.17 And federal officials say the impounded drugs
probably represent only a small fraction of what consumers import illegally.18
Though regulators and academics have been trying to anticipate the impact of
telemedicine for twenty years or more, the phenomenon of online pharmacies seems
to have caught them off guard. That is probably because commentators focused
almost exclusively on “traditional” telemedicine, namely the role of practitioners
who use telecommunications to consult with other practitioners or with patients.
Issues of interstate health care delivery are not new, but the case law is not
particularly well developed for the very reason that cases involving interstate
medicine did not arise that often. Many of the appellate cases, for example, dealt
with choosing the correct state forum for a medical malpractice case.19 Regulatory
concerns seem to have been an afterthought. Even now, regulators and legislators
are focusing far less attention on traditional telemedicine because it doesn’t seem to
have been the source of any major public health problems. By contrast, regulators
fear online pharmacies in the United States and overseas pose a substantial threat to
public health.20
In 1998, after police in Illinois found a man lying unconscious in a hotel parking
lot, FDA officials learned he had purchased a kit to make GHB (an illegal steroid

Online Prescriptions by Physicians Undergoing Increased Scrutiny (1999), at
<http://www.ctl.org/html/alert07191999.htm> (citing several cases involving sanctions against
doctors and pharmacists practicing on the Internet).
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frequently used by bodybuilders) and overdosed on his homemade drugs.21 A fiftytwo year-old Illinois man with episodes of chest pain and a family history of heart
disease died of a heart attack in March 1999 after buying Viagra from an online
source, even though Viagra is not recommended for anyone with heart disease.22
FDA officials say there is no proof linking the man’s death to the drug, but add the
problems likely would have been discovered within the traditional doctor-patient
relationship.23 In any event, FDA official Woodcock said the sheer volume of
electronic drug sales forces FDA officials to rely on “triage” in deciding which cases
to investigate.24
States have also joined the fight against unregulated pharmacies. The attorneys
general of Kansas, Illinois, and Missouri sued out-of-state pharmacies and doctors
who were operating online, and the courts in Kansas and Missouri have issued
injunctions.25 Kansas Attorney General Carla J. Stovall sued seven companies, six
doctors, four other individuals, and three out-of-state pharmacies after a state
investigation uncovered online vendors willing to sell prescription drugs directly to
minors.26 A minor, acting under the direction of one of the agents, was able to
purchase Viagra and the diet-drug Meridia using his true age and his mother’s credit
card.27 The companies did not require parental consent and required no examination
or consultation with a physician.28
Meanwhile, libertarians and even state governments have warned that the FDA
may be trying to extend its regulatory reach too far. One group, the “Life Extension
Foundation,” assailed the FDA for citing the Illinois man who died of a heart attack:
The FDA is using this one death as an example of why the FDA needs to
impose dictatorial power over all health websites. One problem with this
position is that, as of November 1998, at least 130 Americans died from
taking Viagra legally prescribed by their doctors…. The FDA failed to
detect the lethal side effects of Viagra, yet it is now seeking gestapo-like

21

Id.
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Hinkel, supra note 20.
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power to attack any Internet health company it wishes to, without due
process.29
Representatives of state pharmacy boards have been considerably less strident in
their criticism, but are nonetheless wary of a larger FDA role. 30 The National
Assocation of Boards of Pharmacy, which represents the boards of pharmacy of all
U.S. states and territories, and the District of Columbia, has created its own
voluntary certification program and does not want the FDA trying to duplicate state
functions.31
III. WHERE IS CYBERSPACE AND WHAT HAPPENED THERE?
The allegations in the Kansas suit illustrate some of the jurisdictional questions
facing not only pharmacy regulators, but Internet regulators generally. For example,
Attorney General Stovall claimed the defendants sold, and prescribed Viagra “in the
state of Kansas.”32 But the defendant corporation was actually located in Nevada –
so where did the actual sale take place?33 In Kansas, in Nevada, or in the nebulous
realm of cyberspace? Defining “prescribed” and “dispensed” are even more
problematic for Stovall. One could argue that the doctor does the prescribing – the
patient only receives the prescription – and the doctor was not in Kansas. Moreover,
Stovall accused the defendant doctors of practicing medicine in Kansas without a
license from Kansas medical authorities.34 But if the doctor had legal authority to
prescribe in Nevada (leaving aside the issue of whether Nevada allows doctors to
prescribe without an examination) and the prescription was filled in Nevada, then the
question of whether he practiced medicine in Kansas becomes even more complex.
Prior cases in interstate medicine do not really address these issues directly, but
instead the state courts analyzed whether sufficient minimum contacts occurred
between the patient and an out-of-state physician to justify in personam jurisdiction
over the out-of-state physician. Perhaps the most widely cited of these cases is
Wright v. Yackley.35 While living in South Dakota, the plaintiff was treated by the
defendant, a South Dakota doctor.36 The plaintiff later moved to Idaho and asked the
South Dakota doctor to send a copy of her prescription to an Idaho pharmacy.37 The
plaintiff alleged she was injured by the drugs and filed suit against the South Dakota

29
Statement of William Faloon, Vice President, Life Extension Foundation, at
<http://www.lef.org/magazine/mag2000/march00-awsi.html>.
30

Chris Adams, Plan to Curb Drugstores On Web Is Hit, WALL ST. J., Dec. 29, 1999, at
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Stoval v. Focus Med. Group, Inc., No. ___ (Shawnee County Dist. Ct. June 9, 1999).
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doctor in Idaho court.38 The Ninth Circuit cited § 37 of the Restatement (Second) of
Conflict of Laws (1971):
A state has power to exercise judicial jurisdiction over an individual who
causes effects in the state by an act done elsewhere with respect to any
cause of action arising from these effects unless the nature of the effects
and of the individual’s relationship to the state make the exercise of such
jurisdiction unreasonable.39
The court held that jurisdiction in Idaho would be unreasonable because the
defendant was not one who “purposely avails itself of the privilege of conducting
activities within the forum State.”40 However, the court left open the question of
“diagnosis by mail”:
The balance of factors involved in a due process determination might be
different if a doctor could be said to have treated an out-of-state patient by
mail or to have provided a new prescription or diagnosis in such fashion.
In that event, the forum state’s interest in deterring such interstate medical
service would surely be great.41
The court foresaw, quite correctly, that subsequent jurisdictional analyses would
necessarily be made on a case-by-case basis.42 But the court also concluded (albeit
in dicta) that intentionally practicing across state lines would subject the practitioner
to the jurisdiction of the patient’s home state.43
Courts are fairly uniform in finding in personam jurisdiction over practitioners
who deliberately practice across state lines. This is clearly the issue most relevant to
online practitioners, since they are intentionally creating a practice that will cross
jurisdictional boundaries. In McGee v. Riekhof, for example, the defendant was a
Utah surgeon who had performed surgery on a Montana resident in Utah.44 The U.S.
District Court upheld jurisdiction in Montana because the surgeon had, via
telephone, provided a new diagnosis to the patient while the patient was in
Montana.45 This raises an interesting question (one not addressed by the court),
namely whether the Utah surgeon should have held a Montana license to consult
with his patient there. Could Montana medical officials bring charges against the
Utah doctor for practicing in Montana? If so, specialists who treat patients from
around the country – and the world – would need a license in each of the fifty states
in order to consult with a patient by phone. One could argue that a court’s standard

38

Id.

39

Id. at 289.

40

Wright, 459 F.2d at 290 (citing Hanson v. Denckla, 357 U.S. 235, 253 (1958)).

41

Id. at 289.

42

See Prince v. Urban, 49 Cal. App. 4th 1056 (1996) (providing an overview of the case
law regarding in personam jurisdiction over out-of-state practitioners).
43

Wright, 459 F.2d at 289 n.4.

44
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for in personam jurisdiction is different from the regulatory jurisdiction of a state
medical board. Even so, current case law will encourage states to continue asserting
their jurisdiction aggressively (as the states seem to be doing) over out-of-state
practitioners.
IV. WHO GETS TO REGULATE?
Perhaps because of their wariness of the FDA, state boards of pharmacy have
moved quickly to maintain their role in regulating online pharmacies. Acting
through the National Association of Boards of Pharmacy [hereinafter “NABP”], the
states created the Verification of Internet Pharmacy Practice Sites program, or
VIPPS, which will provide a NABP “seal of approval” to sites meeting the
organization’s standards.46 To earn the seal, online pharmacies must be registered
with the pharmacy boards of each of the fifty states and approved to operate in all the
states. 47 To date, only four pharmacies have earned the NABP’s approval.48 In her
July 30, 1999 testimony, Woodcock praised VIPPS – a voluntary partnership
between pharmacies and state regulators – and said “government should encourage
private sector leadership in achieving a safe marketplace.”49 Five months later, the
FDA’s strategy apparently shifted to favor more federal regulation; the White House
released a proposal on Dec. 28, 1999 to increase federal regulation of Internet
pharmacies and to enhance civil penalties.50
Current federal law, i.e. the Food, Drug and Cosmetic Act [hereinafter “FDC”],51
certainly was not written with the Internet in mind. When the first federal food and
drug law was adopted near the turn of the century, pharmacies were the domain of
local merchants, not unlike banks or grocery stores, and regulators were trying to get
a handle on snake oil salesmen. Snake oil salesmen were probably a lesser concern
when the FDC was revised in 1970, but pharmacy still was primarily a local retail
business. (Based on Dr. Woodcock’s testimony, regulators now seem to be shifting
their concern back to the snake oil salesmen…or saleswomen). Though retail
pharmacy has traditionally dominated the market, interstate pharmacy has been
around for quite a while. In fact, Congress made reference to mail-order pharmacy
as early as 1951.52
One might argue that mail-order pharmacies deal only with filling prescriptions
written by a doctor after a traditional, face-to-face encounter with a patient, and
therefore there are no similarities to the online “appointments” between patients and
doctors hired by the online pharmacies. However, Congress inserted a reference to
“diagnosis by mail” in the 1951 amendment to the FDC.53 Interestingly, not a single

46

Website of VIPPS, at <http://www.nabp.org/vipps/intro.asp>.

47

Id.

48

Id.

49

Woodcock, supra note 4.

50

OFFICE OF THE PRESS SECRETARY, supra note 8.

51

21 U.S.C. § 301, et seq. (1999).

52

See S. REP. NO. 82-946 (1951).

53

Id.

172

JOURNAL OF LAW AND HEALTH

[Vol. 15:165

case or commentary on Westlaw makes reference to this brief passage in the FDC,
even though many state and federal courts have grappled with the interstate practice
of medicine. The legislative history does not offer much detail either. According to
the committee report on the 1951 bill that amended the FDC, a representative of a
mail-order company that delivered phenobarbitol to epileptics was present during the
bill’s hearing and objected to some of its provisions.54 The report does not make
clear the portions to which he objected, but the committee altered the bill upon his
recommendation.55
The actual text of the bill (now law) exempts prescriptions from some labeling
requirements, but adds that those filled as part of “diagnosis by mail” are not
exempt.56 The statute certainly does not explicitly authorize anyone to engage in
diagnosis by mail, but instead regulates labeling requirements when diagnosis by
mail occurs.57 A similar Iowa statute was examined by that state attorney general’s
office in 1978, but the opinion did not address the meaning or significance of
diagnosis by mail.58 On the other hand, one might argue that Congress clearly knew
that diagnosis by mail was occurring (a mail-order company representative testified
at the committee hearing), and that Congress took steps to regulate it, therefore
Congress implicitly was sanctioning the practice. Moreover, interstate commerce
and mail-related commerce are the primary domain of Congress, so states arguably
couldn’t impede what Congress had sanctioned. On the whole, however, that
argument seems a bit of a reach.
An explanation of this statute would be helpful because the legal issues
surrounding online pharmacies are so similar to those faced by mail-order
pharmacies. The regulation concerning diagnosis by mail implicitly concedes that
the practice of pharmacy is not clearly divided from the practice of medicine.
“Diagnosis by mail” indicates a physician has diagnosed a patient remotely and is
personally filling and labeling the prescription for delivery to the patient.59 Thus

54

Id.

55

Id.

56

Federal Food, Drug, and Cosmetic Act § 9, 21 U.S.C. § 353(b)(2) (1999). The Act reads
in relevant part:
any drug dispensed by filling or refilling a written or oral prescription of a practitioner
licensed by law to administer such drug shall be exempt from the requirements of
section 352 of this title… if the drug bears a label containing the name and address of
the dispenser, the serial number and date of the prescription or of its filling, the name
of the prescriber, and, if stated in the prescription, the name of the patient, and the
directions for use and cautionary statements, if any, contained in such prescription.
This exemption shall not apply to any drug dispensed in the course of the conduct of a
business of dispensing drugs pursuant to diagnosis by mail, or to a drug dispensed in
violation of paragraph (1) of this subsection.
Id. (emphasis added).
57

Id.

58

Iowa Op. Att’y Gen. 548 (1978), available at 1978 WL 17419.

59

Id. (citing DeFreese v. United States, 270 F.2d 730, 734 n.7 (2d Cir. 1959)) (“It has
always been the rule that a physician who does his own dispensing is also acting in the
capacity of a pharmacist.”).
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legal opinions on the interstate practice of medicine can be relevant to the interstate
practice of pharmacy. But, as previously mentioned, no court has cited this portion of
the statute, much less attempted to apply it, so it is difficult to determine its
significance.
Much of the legal uncertainty concerning interstate pharmacy arises from the
difficulty in determining where state regulation ends and federal regulation begins.
The Supreme Court of Iowa described an “interlocking trellis” of federal and state
regulations governing prescription drugs, and no one seems to dispute that federal
and state roles are intermingled.60 Federal preemption of pharmaceutical regulation
is essentially a patchwork, with Congress expressing a clear intent to dominate some
areas (such as the regulation of nonprescription drugs) but denying any desire to
occupy the field generally. Congress’ failure to explain just how much of the field it
intended to occupy has made issues of preemption difficult to resolve.
All authorities seem to agree that drug regulation is within the traditional police
power of the state and that federal law reserves at least some role for the states.61
Congress stated rather clearly, in fact, that it did not intend to preempt the states’
involvement in drug regulation:
No provision of this title shall be construed as indicating an intent on the
part of Congress to occupy the field in which that provision operates,
including criminal penalties, to the exclusion of any State law on the same
subject matter which would otherwise be within the authority of the State,
unless there is a positive conflict between that provision of this title and
that State law so that the two cannot consistently stand together. 62
Nonetheless, courts have varied widely when asked to decide what does and does
not constitute a “positive conflict” between state and federal laws that govern
prescription drugs.
The Iowa court struck down a state regulation that forbade Iowa pharmacies from
filling prescriptions written by out-of-state practitioners, in part because the court
believed such a rule conflicted with federal policy.63 The court relied on a
description of the federal law’s purpose, as summarized by the U.S. Code
Congressional and Administrative News:
The bill is designed to improve the administration and regulation of the
manufacturing, distribution, and dispensing of controlled substances by
providing for a ‘closed’ system of drug distribution for legitimate handlers
of such drugs. Such a closed system should significantly reduce the
widespread diversion of these drugs out of legitimate channels into the
illicit market, while at the same time providing the legitimate drug
industry with a unified approach to narcotic and dangerous drug control.64
60

Iowa v. Rasmussen, 213 N.W.2d 661 (Iowa 1973).

61

See, e.g., 25 AM. JUR. 2D Drugs and Controlled Substances § 17 (1996).

62

21 U.S.C. § 903 (1999).

63

Rasmussen, 213 N.W.2d at 666.

64

U.S. Code Congressional and Administrative News, 91st Cong., 2d Sess., 1970, Vol. 3,
at 4571-72.
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The court seemed to conclude that out-of-state physicians who complied with the
licensing requirements of their respective states had also met the requirements of the
federal act; therefore, Iowa’s additional requirements impeded the effort to create a
nationalized drug distribution system.65 In an advisory opinion, the Ohio Attorney
General reached a similar conclusion.66
The Texas Attorney General’s Office disagreed with the Iowa court’s conclusion
regarding federal preemption, describing it as “no longer persuasive.”67 However,
Texas officials cited no basis for this conclusion, but instead referred to the portion
of the federal statute dealing with preemption: 21 U.S.C. § 903, the same portion of
the law cited by the Iowa court.68 Thus state courts disagreed on the intended
purpose of the act and therefore disagreed on its intended breadth – i.e., how much of
the field was occupied if Congress did not intend to occupy the entire field.69 The
state courts also disagreed about how much conflict constituted a “positive
conflict.”70
The Court of Appeals of Oregon, for example, expressly rejected the conclusion
of the Iowa Supreme Court in Nichols v. Board of Pharmacy: “Because the Oregon
statute does not authorize what federal law prohibits, and because the limitation it
imposes is consistent with the purpose of the federal statute, we believe that the two
statutes can ‘consistently stand together’ within the meaning of 21 U.S.C. § 903.”71
The court upheld the suspension of an Oregon pharmacist’s license because he
filled a prescription written by an out-of-state practitioner.72
In National
Pharmacies, Inc. v. DeMelecio, the U.S. District Court held that Puerto Rico’s
stringent licensing requirements were within the traditional police powers of the state
and had not been preempted by federal law.73 The court concluded that the
preempted portions of pharmaceutical regulation dealt only with controlled
substances, with “controlled substances” defined as “drugs or medication which have
the potential for abuse and which can cause dependency.”74 Other classes of
prescription medication would not fall within that definition, the court concluded,
therefore Puerto Rico could continue to require that all prescriptions be filled by
pharmacists in Puerto Rico.75
Perhaps unwittingly, the National Pharmacies court raises a strange prospect. If
the court was correct, one can argue that Congress intended to “federalize”
65

Rasmussen, 213 N.W.2d at 666.

66

See Ohio Op. Att’y Gen. No. 82-032 (1982).

67

See Texas Op. Att’y Gen. No. JM-555 (1986).

68

Id.

69

Id.

70

Id.

71

657 P.2d 216 (Or. Ct. App. 1983).

72

Id.

73

51 F. Supp. 2d 45 (D.P.R. 1999).

74

Id. at 54.

75

Id. This case seems to be an aberration, as will be discussed hereinafter.
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regulation of some prescription drugs (“controlled substances”) but not others.76
This is particularly true if the Rasmussen court’s interpretation of the purpose of the
federal act – to create a national “closed system” essentially administered by the
states – is correct.77 Thus federal law would permit a Puerto Rican pharmacist to fill
a New Jersey physician’s prescription for a controlled substance (e.g. morphine)
because that part of the federal regime has preempted state regulation, yet a Puerto
Rican pharmacist could not fill an antibiotic prescription from a New Jersey
physician because that part of the state regulations had not been preempted.
Conversely, a resident of Puerto Rico would be able to purchase morphine from a
nonresident Internet pharmacy but unable to purchase an antibiotic from the same
pharmacy. To date, no court has addressed this potential dichotomy.
In Ferndale Laboratories, Inc. v. Cavendish, the only federal appellate case
dealing with the role of states in interstate pharmaceutical regulation, the Sixth
Circuit (in dicta) favored federal preemption.78 The court concluded the Prescription
Drug Marketing Act of 1987 [hereinafter “PDMA”] granted states only the authority
“to follow federal requirements in licensing wholesale distributors.”79 The PDMA
had been intended to prevent dangerous drugs from escaping the wholesale
distribution system (a sizeable market involving interstate commerce) into the black
market.80 Accordingly, the Ferndale case dealt only with wholesale distributors,81
though one might argue that the principle would apply to all pharmaceutical
distributors dealing in interstate commerce. If that is true, then one could conclude
that states are essentially administrative agents for purposes of interstate drug
regulation. Some support for that argument can be found in the PDMA itself, which
specifically authorizes state and local governments to act as agents of the federal
government in enforcement matters.82 Accordingly, part of the argument for
insisting that states recognize prescriptions from nonresident practitioners might rest
indirectly on the Full Faith and Credit Clause of the Constitution, i.e. if one state
certifies that a practitioner is authorized to act within the federal regime, then another
state must give full faith and credit to the acts of that practitioner. To date, no court
has cited the Full Faith and Credit Clause as having any effect on the interstate
regulation of pharmacies.
V. THE COMMERCE CLAUSE
Several courts have wrestled with the impact of the Commerce Clause –
specifically the “Dormant” Commerce Clause – on regulation of out-of-state
pharmacies. The U.S. Supreme Court set forth the general criteria for Dormant
Commerce Clause decisions in Pike v. Bruce Church, Inc.,83 though much of the case
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law applied to out-of-state pharmacies has been developed in the state courts or by
state attorneys general. The Pike Court struck down a statute which stated a primary
purpose of promoting the reputation of Arizona cantaloupe growers by prohibiting
deceptive packaging and requiring a certain type of packaging before out-of-state
shipment.84 The practical result, as stipulated by the parties, was to require the
plaintiff to build a processing plant in Arizona.85
The Court expressed particular suspicion for regulations that required business
operations be performed in the home state when they could be performed more
efficiently elsewhere:
Where the statute regulates evenhandedly to effectuate a legitimate local
public interest, and its effects on interstate commerce are only incidental,
it will be upheld unless the burden imposed on such commerce is clearly
excessive in relation to the putative local benefits. If a legitimate local
purpose is found, then the question becomes one of degree. And the
extent of the burden that will be tolerated will of course depend on the
nature of the local interest involved, and on whether it could be promoted
as well with a lesser impact on interstate activities.86
In a 1986 opinion for the Texas Board of Pharmacy, the state attorney general’s
office offered a concise summary of the divergent applications of Commerce Clause
doctrine.87 In Pharmaceutical Manufacturers Ass’n v. New Mexico Board of
Pharmacy, for example, the court held that regulations and a licensing fee imposed
by New Mexico on out-of-state pharmacists were reasonable compared with the
state’s interest in drug control.88 The regulations dealt with safe storage and labeling
of drugs and with registration or licensing of pharmacists.89 Similarly, the Wisconsin
Attorney General concluded that the purpose of Wisconsin’s regulations was to
protect the public and that any effect on interstate commerce was incidental.90
In contrast, the Iowa Supreme Court struck down regulations that effectively
prohibited Iowa pharmacists from filling prescriptions written by nonresident
physicians who were not registered with Iowa authorities.91 As noted previously, the
Iowa court struck down the regulation in part because (the court believed) the state
regulations conflicted with federal drug control law.92 But the court also concluded
the regulation was an unnecessary barrier to interstate commerce.93 The Nebraska
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and Ohio Attorneys General similarly concluded that their state’s regulatory schemes
were unconstitutional.94 All the authorities agreed that regulation of prescription
drugs meets the first part of the Commerce Clause test, namely that the regulation
must effect a legitimate local interest. However, under the Pike standard, a
regulation that does not discriminate against out-of-state commerce on its face can
nonetheless violate the Dormant Commerce Clause if its application burdens
interstate commerce beyond the benefits the state derives from the regulation.95 This
latter determination – what constitutes an unreasonable burden – is a mixture of fact
and law that usually is left for the courts to resolve.
One could argue that the Dormant Commerce Clause is now more relevant than
ever to telemedicine because the standards of practice are, in effect, national
standards.96
Although administrative practices might vary from state to state, in the
past 30 years there has been a remarkable convergence in licensing
requirements stipulated by states to license physicians. All states require
the United States Medical Licensing Examination (USMLE). All
recognize appropriate credentials from nationally accredited medical
schools and residency programs regardless of location. All specialty
board certification is conferred by national organizations and are based on
national standards…. In fact, there is little, if any data to support the
claim that physicians of one state are more or less qualified than those of
any other state.97
This is all the more true of pharmacy, which has long been subject to uniform
federal standards. While states regulate practitioners, the federal government has
long had an active role in governing the content of drugs, the labeling of
prescriptions, and even the advertising of prescription and non-prescription drugs.
Accordingly, online pharmacies can argue that the states’ interest in asserting their
police powers against out-of-state pharmacies is moot.
Not surprisingly, different jurisdictions reach different conclusions. For its part,
the Texas Attorney General’s Office advised the state pharmacy board that any rules
it adopted should be “the least burdensome regulation which well effect the state’s
objectives” in order to comply with the Commerce Clause.98 Most courts seem to
agree with this proposition.99 Texas officials also concluded the board “may regulate
out-of-state mail-order pharmacists only to the extent that they actually engage in the
practice of pharmacy or dispense, deliver, or distribute prescription drugs within the
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state of Texas,” i.e. the Texas board could not physically inspect nonresident
facilities that shipped prescriptions into Texas.100
Recent cases seem to support those views. As noted before, the Sixth Circuit
concluded that the PDMA of 1987 granted states only the authority “to follow
federal requirements in licensing wholesale distributors.”101 The case dealt only with
wholesale distributors,102 and wholesale distributors (as opposed to retailers)
presumably would not have nearly the impact on the consumers of other states. But
even in this context, the court concluded it was not unreasonable for Ohio to require
a Michigan distributor to pay a $100 annual registration fee and to keep a record of
the drugs it shipped into Ohio.103 At the very least, states will likely be able to
require registration and production of records that relate to the receiving state. This
is particularly important if the VIPPS program (discussed previously) of the NABP
is to be successful.
But the Sixth Circuit apparently did not persuade the U.S. District Court for the
District of Puerto Rico. The National Pharmacies court upheld rather stringent local
regulations that substantially affect interstate commerce.104 The local regulations
establish strict requirements for the practice of pharmacy that effectively prevent any
pharmacy/pharmacist outside Puerto Rico from filling prescriptions for Puerto Rico
residents.105
In all cases where a pharmacist is practicing his profession, he shall be a member
of the College of Pharmacists of Puerto Rico,106 of age, shall manage in person the
establishment under his supervision, and shall reside in the town in which he is
practicing.107
Section 402 requires that every pharmacy be managed by a pharmacist authorized
to practice in Puerto Rico.108 That section even limits the number of hours per week
that the pharmacist may be absent from the pharmacy.109
The National Pharmacies case arose when Blue Cross of Puerto Rico entered a
contract with National Pharmacies, Inc. of New Jersey for mail-order drug delivery
to Blue Cross customers in Puerto Rico.110 The Puerto Rican government sought to
ban National from serving customers in Puerto Rico because it was located in New
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Jersey and it and its pharmacists did not meet the requirements of Puerto Rican
law.111 In siding with the government, the court concluded Puerto Rican law was not
preempted by federal drug law (as discussed previously).112 The court also held that
Puerto Rican law did not violate the Dormant Commerce Clause.113 This latter
holding seems particularly difficult to reconcile with prior case law, particularly
Pike:
For the Court has viewed with particular suspicion state statutes requiring
business operations to be performed in the home State that could more
efficiently be performed elsewhere. Even where the State is pursuing a
clearly legitimate local interest, this particular burden on commerce has
been declared to be virtually per se illegal.114
Interestingly, the National Pharmacies court cites none of the cases cited thus far
except Ferndale, and it cites that case only with reference to the police powers of
Puerto Rico.115 The plaintiffs seem to have had strong grounds for an appeal though
apparently none was filed.
VI. LIMITS TO REGULATION
Whatever laws the states or federal government adopt, the practical barriers to
regulation are enormous. First and foremost, regulators in the United States are
dealing with pharmacies that can appear on the Internet without warning and then
disappear overnight. Even if regulators can figure out the location of the host
computer, they still may not know the state – or country – in which the drugs are
stored and dispensed. In the unusual event regulators close an online pharmacy, the
owners can reopen under another name, through another corporation, and/or from a
different location. Federal regulators acknowledge the seemingly insurmountable
obstacles,116 but are nonetheless asking for an additional $10 million to hire new
personnel to regulate online pharmacies.117 Interestingly, former President Clinton’s
fellow Democrats questioned whether the Administration really knew what it
needed, or whether it arrived at the $10 million figure arbitrarily.118
VII. FOREIGN PHARMACIES
Pharmaceuticals frequently cost far less outside the U.S. market, even when the
drug is the same and is manufactured by the same company.119 To dramatize the
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difference between U.S. and foreign drug prices, Congressman Bernard Sanders
accompanied six senior citizens from Vermont to a Montreal pharmacy in July 1999;
one woman in the group paid $12.08 for sixty tamoxifen pills (used to treat breast
cancer), but she would have paid more than $100 for that amount in the United
States.120 Internet entrepreneurs have used these price differences to their advantage.
For a $10.95 monthly subscription to the BDZI Pharmacy Watch Web site, the
company provides access to pharmacies worldwide and advice on getting the drugs
into the United States.121 “Access to Mexican, Foreign and American Doctors from
our web site that will write you prescriptions, if needed,” claims the site.122 One
group that favors deregulating prescription drugs publishes on its Web site a
comparison of brand-name drugs in Europe that cost as little as one-tenth the price of
the same drug in the United States.123 On the other hand, proponents of regulation
argue that products available in some countries, particularly Mexico, may be of
inferior quality or may be held for retail sale in sub-optimal conditions.124
Whether good or bad, the fact remains that the drugs are imported. Furthermore,
if online pharmacies in the United States seem difficult to regulate, they are hardly as
unregulated as online pharmacies in other countries. Most countries, including those
of the European Union, have always been far less stringent regulators of prescription
drugs than the United States.125 Many drugs available only by prescription in the
U.S. can be purchased over the counter elsewhere, so it should come as no surprise
that many pharmacies in those countries put forth little effort (if any) to insure U.S.
patients have a prescription.126
Thus foreign pharmacies present all the practical regulatory hurdles of any other
online pharmacy, plus additional jurisdictional and legal obstacles. On the practical
side, Internet entrepreneurs in Europe have been sending marijuana seeds to the
United States via mail for years, and the same methods are readily transferable to
online pharmacies outside the United States.127 The seller may be located in a
country that does not cooperate with U.S. enforcement efforts or, if not, the seller
may store its server and customer information in a third country. A secure online
transaction can protect a purchaser in the United States from government detection,
and the seller simply ships the illicit item in a nondescript container with no return
address or a bogus return address. Some pharmacies in Mexican border towns even
120
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offer packaging of illegal drugs in tamper-proof sealed aspirin bottles to allay the
suspicions of Customs officials.128 Undoubtedly these techniques have been adopted
by online pharmacies as well.
Free-trade treaties may also pose problems for regulators, particularly the North
American Free Trade Agreement [hereinafter “NAFTA”]. Though NAFTA
generally does not preclude federal public health regulations, including prescription
drug regulations, it does nonetheless preclude state governments from enacting
regulations on Mexican and Canadian imports, i.e. only the federal government can
regulate imports from a NAFTA partner.129 No state government has yet tried to act
against a pharmacy in Mexico or Canada, but any such effort would almost certainly
fail even if an injunction were sought in federal court. The state laws enforced by
the Kansas, Missouri, and Illinois courts on pharmacies in other states would
presumably be preempted by NAFTA if the courts sought to apply them to a
pharmacy in Mexico or Canada.
On the other hand, one could argue that states are entitled to act against imports
from a Mexican or Canadian pharmacy via the FDC, which specifically authorizes
state and local governments to act as agents in enforcing federal drug laws.130
Accordingly, a state attorney general might have standing to bring a claim in federal
court under federal drug control laws against a Mexican or Canadian pharmacy
because the state official is acting in a federal capacity. The state might argue that
the practitioners and pharmacies outside the U.S. are not licensed within the meaning
of the FDC because it implicitly referred to professional licenses granted by the
States. That argument has not been confronted, much less resolved, by U.S. courts.
In any event, state governments appear to have more authority to prevent imports
from other states than from Canada or Mexico.
This begs the question why any state official should want to regulate online
pharmacies in the first place. Internet commerce is unique in that the smallest
vendor immediately becomes a nationwide and perhaps worldwide vendor.
Enforcement incentives are altered dramatically because geography loses its
relevance. Prior to e-commerce, a rogue pharmacist and his customers probably
were all within driving distance of the pharmacy. Thus the harm was almost
exclusively local, and local regulators had incentive to act. Conversely, the online
pharmacy that sells Viagra to teenagers in Kansas will also sell Viagra to teenagers
in the other forty-nine states. Kansas can argue that it should not have to shoulder
the responsibility of what is in essence a national threat to public health. In fact, the
Texas Board of Pharmacy has made that very argument: “We just don’t have the
personnel to spend a long time on the Internet searching for [rogue pharmacies],”
said Gay Dodson, executive director of the Texas Board of Pharmacy. She
continued, “we… could go out and look every day to see what’s out there, but sites
pop up just overnight.”131 Her ten investigators handled 1500 complaints in 1998,
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and another five employees were responsible for inspecting the state’s 5000
pharmacies.132
Aside from lower prices, foreign online pharmacies hold another advantage over
online pharmacies in the United States. At the height of the AIDS scare in the late
1980’s, AIDS activists demanded immediate access to potential treatments that were
available overseas but not in the United States.133 A July 20, 1988, FDA memo
opened the door to these imports.134 Importing drugs unapproved by the FDA was
(and still is) flatly prohibited by law, but the FDA used its enforcement discretion to
allow U.S. consumers to import up to ninety days’ worth of drugs for personal use.135
The policy is designed to allow U.S. residents to purchase drugs not approved by the
FDA if (1) the patient is using the drug under the care of a physician and (2) the drug
is not available in the United States.136 The latter stipulation is more significant than
it may appear – according to the policy, patients cannot purchase a drug that is
available in the United States, e.g. a U.S. patient could not purchase Prozac from a
foreign pharmacy because Prozac is available in the United States.137 In practical
terms, this policy prevents U.S. customers from bypassing the U.S. retail drug
market in favor of much lower retail prices in other countries.
However, there are exceptions to the exception. A U.S. resident can purchase a
drug from a foreign pharmacy even if that drug is available from U.S. pharmacies,
but only if the FDA has certified and approved the manufacturing source (a single
drug such as Prozac may be manufactured in different locations for different
markets).138 And there is an exception to the limitation of the exception: even if the
FDA has not approved the manufacturing source, FDA enforcement standards allow
the drug to be delivered to the U.S. customer with a simple warning that the FDA
cannot vouch for the safety of the product.139 In other words, it is possible to buy
almost any drug from a foreign pharmacy, regardless of whether it is available in the
U.S. and regardless of whether the FDA approved the manufacturing source, so long
as the enforcement agent is willing to exercise his or her discretion. And FDA
guidelines encourage enforcement agents to do just that: “We must remember the
132
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consumer protection provided by unlimited, extensive coverage of mail imports is
not commensurate with the resources that are expended,”140 and “[g]enerally, little
time should be spent on the coverage of mail importations.”141
However popular the end result may be with AIDS activists, this discretionary
enforcement strategy presents the same problems as any other discretionary
enforcement strategy. First and foremost, discretionary enforcement creates legal
and regulatory uncertainty and is ripe for favoritism or abuse. Though there is no
evidence of favoritism or abuse in enforcing drug import laws, the evidence of legal
and regulatory uncertainty is compelling. By its own admission, the extent to which
drug import laws had been enforced by the FDA varied widely between the different
regions and field offices.142 One memo suggests some Customs enforcement districts
detain all imported prescription drugs, while other districts detain none: “Surveys
have shown a significant variance among the districts in the area. A typical example
is the district’s coverage of mail importations which varies from 0% to 100%. Such
unequal enforcement is unfair to both the consuming public and the trade.”143 If the
FDA’s own regulators and enforcement officials could not agree on what should and
should not be cleared for delivery, one can hardly expect patients and suppliers to
know what can or cannot be shipped. Though the FDA memo was intended to clear
up this confusion, it is not clear whether the memorandum made the level of
enforcement any more uniform among the different FDA regions and field offices.
VIII. POSSIBLE SOLUTIONS
While states have traditionally resisted federal incursion into professional
licensing, online pharmacies could force the federalization (at least partially) of both
medical and pharmaceutical licensing. NAFTA alone could force the federal
government to expand its role because states will be largely powerless to enforce
their own laws against Canadian and Mexican pharmacies.
Expanding federal regulation into an area traditionally overseen by the states
certainly is not without precedent, and expansion of the federal role hasn’t
necessarily meant the federal government occupied the field or even assumed direct
control over licensing. A relevant example is the Commercial Motor Vehicle Safety
Act of 1986, which set minimum standards for commercial tractor-trailer and bus
drivers.144 Prior to the Act, state licensing standards varied widely, and commercial
drivers frequently obtained licenses from more than one state.145 Drivers could hide
or spread convictions among several driving records and continue driving.146 The
CMVSA allowed states to continue issuing drivers licenses, but it required them to
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observe minimum national standards when licensing commercial drivers, and it
forbade drivers from having a license in more than one state.147
Likewise, federal regulation of medical practice may not be too far a leap from
the current scheme. The federal government is already involved in monitoring
medical practitioners, even though states still license all healthcare professionals.148
The U.S. Department of Health and Human Services maintains the National
Practitioner Data Bank to keep track of complaints against physicians, and some
members of Congress want to open the database to the public.149
According to the American Telemedicine Association [hereinafter “ATA”], three
basic approaches have been offered for regulating telemedicine:150
1) Full and Unrestricted Licensure: Each telemedicine practitioner would need
a license in any state in which he/she consulted a patient via the Internet.
States would decide issues of reciprocity in a way similar to the drivers
license compact between the states, if they chose to allow reciprocity at all.
2) Limited Licensure: Practitioners would be licensed in the states in which
they treat patients face-to-face, and a secondary or limited license would be
granted for practice via telemedicine. The secondary license could be
granted by the states individually or by the federal government.
3) National Licensure: The federal government would assume control over all
practitioner licensing.151
The ATA supports limited licensure, as does the Federation of State Medical
Boards [hereinafter “FSMB”].152 The FSMB produced “A Model Act to Regulate
Practice of Telemedicine or Medicine by Other Means Across State Lines,” which
would establish the secondary license state-by-state.153 As of May 21, 1999, only
three states (Alabama, Tennessee, and Texas) had adopted legislation consistent with
the Model Act.154 Conversely, fourteen states had adopted legislation requiring full
and unrestricted licensure in the previous four years.155
Regardless of lawmakers’ wishes, prescription drug regulation will most likely
move from a licensing model to a certification model. Practical considerations make
this inevitable because, aside from expanding the “war on drugs” to prescription
pharmaceuticals, there is little the federal government can do to prevent U.S.
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consumers from ordering the drugs they want from a foreign pharmacy.156 To some
extent, federal officials have acknowledged as much.157
Yet concerns about consumer protection and public health and safety are not
diminished with the advent of online pharmacies. On the contrary, one might argue
that these concerns are magnified. As previously discussed, enforcing regulations in
cyberspace can be difficult under the best of circumstances; online pharmacies can
appear and disappear overnight. Tort recovery is highly unlikely if the pharmacy is
located in another country. Accordingly, regulators are forced to rely on
professional certification rather than licensure. Programs like VIPPS could be,
perhaps, expanded to an international scale. Moreover, national certifications would
acquire brand name value. Most U.S. consumers probably wouldn’t purchase an
unknown cancer treatment manufactured and sold in Nigeria, but U.S. consumers
already have already demonstrated their willingness to buy pharmaceuticals from
European sources.158 That can most likely be attributed to confidence in European
drug regulation.
IX. BENEFITS TO CONSUMERS
At the least, one can argue that the result of imports from foreign online
pharmacies is egalitarian – no longer must a U.S. resident live near the border or fly
to Europe for drugs that are unavailable in the U.S. The competitive pressures of
international retail drug trade could lower drug costs for consumers worldwide. In
fact, the competition is already under way. The National Community Pharmacists
Association is pressing Congress to allow retailers to buy drugs overseas – where
prices are a fraction of the amount charged in the U.S. – for reimport into the United
States.159 If the FDA maintains a fairly liberal import policy, the “brand name” value
of each nation’s certification could result in a sort of competition between regulatory
agencies. For example, if U.S. consumers decide the FDA’s drug approval process
takes too long and is unnecessarily stringent, they may decide instead to trust the
somewhat less-stringent approval process of a European country and purchase a drug
that is already approved in Europe but not in the U.S. In fact, the growing business
of importing drugs not available in U.S. pharmacies seems to indicate consumers
have done just that. Thus regulatory drug approval might become more like an
Underwriter’s Laboratories listing: consumers would decide for themselves whether
FDA approval was worth the wait (and manufacturers might debate whether it was
worth the cost) when another country has already approved the drug. Critics might
argue the option to purchase desired drugs from foreign pharmacies could result in
competitive pressures on the FDA, which in turn might shortcut its evaluation
156
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process to keep pace with European agencies. On the other hand, manufacturers
might argue that the competitive pressure could force the FDA to strike a better
balance between consumer protection and consumer demand. Understandably, the
FDA may not wish to throw the borders open to just any pharmaceutical import, but
the emergence of international manufacturing standards should give the FDA a better
idea of which countries provide reasonable guarantees of safety and which do not.
X. AN UNKNOWN
As stated before, one would presume that the practice of medicine – including the
aspects that relate to prescription drugs – should be the same regardless of the state.
However, this presumption is not completely true. Oregon, for example, licenses
naturopathic160 doctors to prescribe under the FDC, a practice that has produced
considerable criticism from other practitioners.161 Other states might object that they
do not consider naturopaths adequately trained to prescribe drugs, and that under no
circumstances would they want an out-of-state naturopath prescribing drugs to an instate resident. Presumably, a state could authorize chiropractors or even pharmacists
to prescribe drugs. In fact, some twenty-eight U.S. states allow pharmacists limited
authority to consult with patients, write prescriptions, and fill the prescriptions they
write.162 But powerful physician’s associations such as the American Medical
Association almost certainly would fight any attempt to give full prescribing powers
to pharmacists (or chiropractors), and it is unlikely that any state government would
extend such authority to pharmacists.
However, the issue may not be so straightforward with American Indian tribes.
Courts are increasingly recognizing tribal sovereignty to include almost all areas of
civil regulation.163
Tribal governments exert authority over wildlife,164
165
environmental affairs, and family law,166 and now some tribes are expanding their
reach into gambling,167 corporation law,168 and even automobile licensing.169
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Medical practice is hardly booming on Indian lands. Physicians generally are
provided by the U.S. Indian Health Service,170 so the adoption of professional
medical/pharmaceutical regulation is unlikely to be guided by a politically prominent
organization tantamount to a state or national medical association. On the other
hand, health care could become a major industry on tribal lands if online pharmacies
move there to take advantage of more favorable regulations. A tribe might, for
example, permit pharmacists to write prescriptions themselves and to do it on the
basis of an online form or interview. While it is clear that the FDC gives states
substantial latitude to determine who is or is not qualified to write prescriptions, the
FDC makes no mention of tribal governments, much less whether they can license
professionals to act within the FDC.171
Tribal pharmacy regulation has not been an issue because most pharmacists who
work on Indian lands are federal employees, and those who are not federal
employees (as well as those who are federal employees) are licensed by a state
pharmaceutical board (even if it is not the state in which the tribal lands are
located).172 The states can exert some authority over the pharmacists they license,
even when those pharmacists practice on Indian land.173 However, the states have no
authority to regulate or inspect the facilities of pharmacies on Indian land.174
The unanswered question is what rights – if any – the pharmacies and
pharmacists licensed by a tribe would have beyond tribal lands. As previously noted,
the courts haven’t yet resolved the impact of the Dormant Commerce Clause on state
regulation of online pharmacies. The FDC makes no mention of tribal governments,
but since Congress maintains sole authority to regulate commerce with Indian tribes,
one could argue that tribal drug regulations would be subject to the same analysis as
state drug regulations.
Internet commerce in general presents promising
opportunities for economic growth on reservations, many of which are isolated from
major population centers. Because of the unique legal authority of tribal
governments and the near irrelevance of geography in Internet commerce, Indian
territory may prove to be a popular location for online pharmacies. If so, Congress
will be faced with yet another challenge to traditional drug regulation.
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